“Safety of Rituximab in the Routine Treatment of Rheumatoid Arthritis in Italy in Patients Refractory to Anti-TNFa Drugs: Results from the Observational Retrospective-Prospective RUBINO Study”. 2014. Reumatismo 66 (3): 224-32. https://doi.org/10.4081/reumatismo.2014.748.